Court Won't Stay Generic Approval Of HDI Body Oil

Law360, New York (December 3, 2007, 12:00 AM EST) -- Dermatological products manufacturer Hill Dermaceuticals Inc. has come up short in its bid for a stay to prevent the U.S. Food & Drug Administration from approving any generic version of its brand-name scalp and body oil until the agency fully responds to its citizen petition.

Judge Royce C. Lamberth of the U.S. District Court for the District of Columbia concluded on Thursday that the FDA complied with regulations by offering HDI a tentative response and denied HDI’s attempt to stop the FDA from passing through generic...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.